DCA Unearths Spurious Medicine Racket In Vijayawada

Vijaywada : The Department of Drugs Control Administration of the State government has busted a spurious drug racket in Vijayawada.

The Drugs Inspector has established that certain drugs manufactured by reputed pharma companies are imitated, and manufactured in a manner that would deceive unsuspecting consumers. The department further learnt that the unauthorised dealers are supplying substandard medicines by falsely labelling them as products manufactured by a reputed pharma company.

These counterfeit and spurious drugs would cause severe and fatal damage to one’s health as they are not manufactured by the original drug companies. The materials used in the drugs and the conditions being maintained at the manufacturing facility are of dubious quality, and it is likely that the ingredients can be toxic and can even cause death, said B. Anvesh Reddy, Drugs Inspector, Vijayawada Zone-IV of the Drug Control Administration in his complaint lodged with the Bhavanipuram police in Vijayawada on September 6 (Wednesday). The Hindu has accessed the complaint of the Drugs Inspector, a copy of the First Information Report (FIR) and other laboratory findings related to the drug racket.

The FIR has been registered against P.D.M.K.R.G. Krishna Murthy, of Lakshmi Padmavathi Pharma at Vasavi Pharma Market Complex in Vijayawada, and N. Kiran Kumar of Vidyadharapuram in Vijayawada under Sections 420 (cheating and dishonestly inducing delivery of property), 471 (using as genuine a forged document), 274 (adulteration of drugs) and 275 (selling adulterated drugs) of the Indian Penal Code (IPC).

Related Posts

  • Pharma
  • May 27, 2025
  • 81 views
Stock market update: Nifty Pharma index advances 0.11%

NEW DELHI: The Nifty Pharma index closed on a positive note on Tuesday. Shares of Granules India Ltd.(up 1.7 per cent), Laurus Labs Ltd.(up 1.14 per cent), Mankind Pharma Ltd.(up…

  • Pharma
  • May 27, 2025
  • 139 views
Amrut Medhekar to exit Akums Drugs and Pharma as CEO-CDMO Business

New Delhi:  Akums Drugs and Pharma has announced the resignation of Amrut Medhekar, CEO- CDMO Business of the Company effective July 15 to pursue new opportunities and challenges. “In terms…

Leave a Reply

Your email address will not be published. Required fields are marked *

You Missed

Stock market update: Nifty Pharma index advances 0.11%

Stock market update: Nifty Pharma index advances 0.11%

Amrut Medhekar to exit Akums Drugs and Pharma as CEO-CDMO Business

Amrut Medhekar to exit Akums Drugs and Pharma as CEO-CDMO Business

Ramping Up Community for JeevanRaksha during Disasters

Ramping Up Community for JeevanRaksha during Disasters

Absconding for years, mastermind behind inter-state illegal drug syndicate lands in police net

Absconding for years, mastermind behind inter-state illegal drug syndicate lands in police net